A comment to: Predictors of low-density lipoprotein cholesterol target value attainment in the DYSIS II Europe Study

Abstract

Get full access to this article

View all access options for this article.

References

Ferrieres

De Ferrari

Hermans

et al.

Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe. Eur J Prev Cardiol. 2018; 25: 1966–1976.

LaRosa

Grundy

Waters

et al.

Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425–1435.

Cannon

Blazing

Giugliano

et al.

Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 2015; 372: 2387–2397.

Sabatine

Giugliano

Keech

et al.

Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 2017; 376: 1713–1722.

Pedersen

Butrymovich

Kelbæk

et al.

Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol 2014; 64: 2101–2108.

Galløe

Kelbæk

Thuesen

et al.

10-Year clinical outcome after randomization to treatment by sirolimus- or paclitaxel-eluting coronary stents. J Am Coll Cardiol 2017; 69: 616–624.

Cannon

Braunwald

McCabe

et al.

Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495–1504.

Müller-Wieland

Assmann

Carmena

et al.

Treat-to-target versus dose-adapted statin treatment of cholesterol to reduce cardiovascular risk. Eur J Prev Cardiol 2016; 23: 275–281.

Munkhaugen

Sverre

Otterstad

et al.

Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients. Eur J Prev Cardiol 2017; 24: 981–989.

10.

Kotseva

De Bacquer

De Backer

et al.

Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions. Eur J Prev Cardiol 2016; 23: 2007–2018.